Table 1
Pediatric Cancer Incidence in Idaho, 1982-1996
International Classification of Childhood Grouping |
Incidence Counts, 15 Year Total |
Percent of Total Cases |
Crude Rates 15 Year Average |
Age-Adjusted Rates 1982-1996 |
US Age-Adjusted Rates 1990-1994 |
Expected Cases Idaho |
P-value |
| Age 0-4
| Age 5-9
| Age 10-14
| Age 0-14
|
| Age 0-4
| Age 5-9
| Age 10-14
|
| All Races
| Whites
|
|
|
All Cancers |
268 |
150 |
184 |
602 |
100% |
202.6 |
110.7 |
136.5 |
147.2 |
139.7 |
142.9 |
586.7 |
0.538 |
Leukemias |
91 |
44 |
54 |
189 |
31% |
68.8 |
32.5 |
40.1 |
46.0 |
43.1 |
45.2 |
187.7 |
0.942 |
Lymphocytic leukemia |
76 |
34 |
37 |
147 |
24% |
57.4 |
25.1 |
27.5 |
35.5 |
34.0 |
36.4 |
151.7 |
0.743 |
Acute non-lymphocytic leukemia |
11 |
6 |
11 |
28 |
5% |
8.3 |
4.4 |
8.2 |
6.9 |
6.6 |
6.5 |
26.5 |
0.819 |
Lymphomas & Other Reticuloendothelial Neoplasms |
12 |
24 |
33 |
69 |
11% |
9.1 |
17.7 |
24.5 |
17.6 |
15.3 |
15.7 |
61.5 |
0.369 |
Hodgkin's Disease |
2 |
8 |
13 |
23 |
4% |
1.5 |
5.9 |
9.6 |
5.9 |
6.2 |
6.5 |
24.7 |
0.839 |
Non-Hodgkin's Lymphoma |
3 |
10 |
11 |
24 |
4% |
2.3 |
7.4 |
8.2 |
6.1 |
5.8 |
5.8 |
23.0 |
0.888 |
CNS & Misc. Intracranial & Intraspinal Neoplasms |
50 |
45 |
25 |
120 |
20% |
37.8 |
33.2 |
18.6 |
29.3 |
30.3 |
31.0 |
126.1 |
0.624 |
Astrocytoma |
29 |
25 |
12 |
66 |
11% |
21.9 |
18.4 |
8.9 |
16.1 |
14.6 |
15.2 |
61.1 |
0.560 |
Medulloblastoma |
5 |
9 |
7 |
21 |
3% |
3.8 |
6.6 |
5.2 |
5.3 |
7.3 |
7.7 |
31.6 |
0.060 |
Sympthetic Nervous System Tumors |
36 |
1 |
1 |
38 |
6% |
27.2 |
0.7 |
0.7 |
8.6 |
9.4 |
9.8 |
43.1 |
0.489 |
Neuroblastoma & ganglioneuroblastoma |
36 |
0 |
1 |
37 |
6% |
27.2 |
- |
0.7 |
8.3 |
9.0 |
9.5 |
41.8 |
0.517 |
Retinoblatomas |
10 |
0 |
0 |
10 |
2% |
7.6 |
- |
- |
2.2 |
3.8 |
3.6 |
15.6 |
0.182 |
Renal Tumors |
33 |
9 |
0 |
42 |
7% |
24.9 |
6.6 |
- |
9.7 |
7.7 |
7.8 |
33.3 |
0.162 |
Wilms' Tumors |
31 |
9 |
0 |
40 |
7% |
23.4 |
6.6 |
- |
9.2 |
7.4 |
7.6 |
32.5 |
0.224 |
Hepatic Tumors |
2 |
1 |
1 |
3 |
0% |
1.5 |
0.7 |
- |
0.7 |
1.9 |
2.0 |
8.6 |
0.055 |
Malignant Bone Tumors |
2 |
7 |
25 |
34 |
6% |
1.5 |
5.2 |
18.6 |
8.9 |
6.9 |
7.3 |
28.0 |
0.302 |
Osteosarcoma |
2 |
2 |
15 |
19 |
3% |
1.5 |
1.5 |
11.1 |
5.0 |
3.9 |
3.9 |
15.0 |
0.357 |
Ewing's Sarcoma |
0 |
5 |
7 |
12 |
2% |
- |
3.7 |
5.2 |
3.1 |
2.4 |
2.8 |
10.6 |
0.757 |
Soft Tissue Sarcoma |
19 |
8 |
20 |
47 |
8% |
14.4 |
5.9 |
14.8 |
11.6 |
9.4 |
9.2 |
37.1 |
0.132 |
Rhabdomyosarcoma & embryonal sarcoma |
12 |
5 |
11 |
28 |
5% |
9.1 |
3.7 |
8.2 |
6.9 |
4.7 |
4.8 |
19.8 |
0.095 |
Germ Cell, Trophoblastic & Other Gonadal Neoplasms |
12 |
3 |
11 |
26 |
4% |
9.1 |
2.2 |
8.2 |
6.4 |
5.3 |
4.9 |
19.9 |
0.220 |
Other Epithelial & Unspecified Neoplasms |
1 |
8 |
15 |
24 |
4% |
0.8 |
5.9 |
11.1 |
6.3 |
6.7 |
6.5 |
25.6 |
0.846 |
Study
Table 1
Table 2
Table 3
Table 4
Table 5
Appendix